Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Spinal Cerebral Ataxia (SCA) Type-12 is 10 days.

What are the prerequisites for the test Spinal Cerebral Ataxia (SCA) Type- 12

  • Genetic counseling
  • Fasting for 12 hours before blood sample collection
  • Medical history documentation
  • Physical examination
  • Consent form signed by the patient or legal guardian

What are the measure values for the test Spinal Cerebral Ataxia (SCA) Type- 12

  • Age of onset: Typically in adulthood
  • Progression: Slow progression of symptoms
  • Symptoms: Cerebellar ataxia, dysarthria, nystagmus
  • Genetic mutation: CACNA1G gene mutation
  • Inheritance pattern: Autosomal dominant

What does this test Spinal Cerebral Ataxia (SCA) Type- 12 identify?

Test for Spinal Cerebellar Ataxia (SCA) Type-12

This test is used to identify the presence of Spinal Cerebellar Ataxia (SCA) Type-12. SCA Type-12 is a genetic disorder that affects the nervous system and leads to coordination and balance problems.

The test typically involves genetic testing to identify mutations in the NOP56 gene, which is associated with SCA Type-12. By analyzing the genetic material, doctors can determine if a person carries the mutation that causes SCA Type-12.

Early diagnosis of SCA Type-12 is important as it can help in managing symptoms and providing appropriate care and support to individuals affected by the condition.

Why is this test Spinal Cerebral Ataxia (SCA) Type- 12 taken?

Spinal Cerebellar Ataxia (SCA) Type-12 Test

The test for Spinal Cerebellar Ataxia (SCA) Type-12 is taken to diagnose and confirm the presence of this specific type of ataxia. SCA Type-12 is a rare genetic disorder that affects the coordination and balance of an individual. Symptoms of SCA Type-12 may include gait abnormalities, difficulty with speech and swallowing, and involuntary eye movements.

The test for SCA Type-12 involves genetic testing to identify mutations in the PPP2R2B gene, which is associated with this type of ataxia. By identifying these mutations, healthcare providers can accurately diagnose SCA Type-12 and provide appropriate treatment and management strategies.

Popular FAQs on Test

SCA Type-12 is a rare genetic disorder that affects the nervous system, specifically causing problems with coordination and balance.
Symptoms of SCA Type-12 may include poor coordination, unsteady walk, slurred speech, and difficulty with fine motor skills.
SCA Type-12 is typically diagnosed through genetic testing to identify the specific gene mutation associated with the disorder.
There is currently no cure for SCA Type-12, but treatment options are available to help manage symptoms and improve quality of life.
The prognosis for individuals with SCA Type-12 varies depending on the severity of symptoms and how early the disorder is diagnosed. Some individuals may experience a slower progression of symptoms while others may experience more rapid deterioration.

Customer Google Rating